159 related articles for article (PubMed ID: 35131686)
21. Does stage at diagnosis influence the observed relationship between socioeconomic status and breast cancer incidence, case-fatality, and mortality?
Yabroff KR; Gordis L
Soc Sci Med; 2003 Dec; 57(12):2265-79. PubMed ID: 14572836
[TBL] [Abstract][Full Text] [Related]
22. The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands.
Kuijer A; Verloop J; Visser O; Sonke G; Jager A; van Gils CH; van Dalen T; Elias SG
Ann Oncol; 2017 Aug; 28(8):1970-1978. PubMed ID: 28459994
[TBL] [Abstract][Full Text] [Related]
23. Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.
Falstie-Jensen AM; Kjærsgaard A; Lorenzen EL; Jensen JD; Reinertsen KV; Dekkers OM; Ewertz M; Cronin-Fenton DP
Breast Cancer Res; 2019 Mar; 21(1):44. PubMed ID: 30902106
[TBL] [Abstract][Full Text] [Related]
24. The relative effect of mammographic screening on breast cancer mortality by socioeconomic status.
Ripping TM; van der Waal D; Verbeek ALM; Broeders MJM
Medicine (Baltimore); 2016 Aug; 95(31):e4335. PubMed ID: 27495038
[TBL] [Abstract][Full Text] [Related]
25. Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer.
Aalders KC; van Bommel AC; van Dalen T; Sonke GS; van Diest PJ; Boersma LJ; van der Heiden-van der Loo M
Eur J Cancer; 2016 Aug; 63():118-26. PubMed ID: 27299664
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer stage at diagnosis and area-based socioeconomic status: a multicenter 10-year retrospective clinical epidemiological study in China.
Wang Q; Li J; Zheng S; Li JY; Pang Y; Huang R; Zhang BN; Zhang B; Yang HJ; Xie XM; Tang ZH; Li H; He JJ; Fan JH; Qiao YL
BMC Cancer; 2012 Mar; 12():122. PubMed ID: 22455370
[TBL] [Abstract][Full Text] [Related]
27. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
28. Socioeconomic status significantly contributes to the likelihood of immediate postmastectomy breast reconstruction in the Netherlands: A nationwide study.
Filipe MD; Siesling S; Vriens MR; van Diest PJ; Witkamp AJ; Mureau MAM
Eur J Surg Oncol; 2021 Feb; 47(2):245-250. PubMed ID: 32981793
[TBL] [Abstract][Full Text] [Related]
29. Socioeconomic Disparities and Mortality After a Diagnosis of Dementia: Results From a Nationwide Registry Linkage Study.
van de Vorst IE; Koek HL; Stein CE; Bots ML; Vaartjes I
Am J Epidemiol; 2016 Aug; 184(3):219-26. PubMed ID: 27380760
[TBL] [Abstract][Full Text] [Related]
30. Metachronous contralateral breast cancer as first event of relapse.
de la Rochefordière A; Mouret-Fourme E; Asselain B; Scholl SM; Campana F; Broët P; Fourquet A
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):615-21. PubMed ID: 8948346
[TBL] [Abstract][Full Text] [Related]
31. Disparities in survival of stomach cancer among different socioeconomic groups in North-East Netherlands.
Siemerink EJ; Hospers GA; Mulder NH; Siesling S; van der Aa MA
Cancer Epidemiol; 2011 Oct; 35(5):413-6. PubMed ID: 21470931
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer mortality of older patients with and without recurrence analysed by novel multi-state models.
de Boer AZ; Bastiaannet E; Schetelig J; de Glas NA; Manevksi D; Putter H; Liefers GJ; de Munck L; Portielje JEA; de Wreede LC
Eur J Cancer; 2022 Oct; 174():212-220. PubMed ID: 36058128
[TBL] [Abstract][Full Text] [Related]
33. Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
Wilson S; Speers C; Tyldesley S; Chia S; Kennecke H; Ellard S; Lohrisch C
Clin Breast Cancer; 2016 Aug; 16(4):284-90. PubMed ID: 26705158
[TBL] [Abstract][Full Text] [Related]
34. Conditional regional recurrence risk: The effect of event-free years in different subtypes of breast cancer.
Vane MLG; Moossdorff M; van Maaren MC; van Kuijk SMJ; van Nijnatten TJA; van Roozendaal LM; Boerma EG; de WIlt JHW; Smidt ML
Eur J Surg Oncol; 2021 Jun; 47(6):1292-1298. PubMed ID: 33349525
[TBL] [Abstract][Full Text] [Related]
35. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity.
Smith EC; Ziogas A; Anton-Culver H
JAMA Surg; 2013 Jun; 148(6):516-23. PubMed ID: 23615681
[TBL] [Abstract][Full Text] [Related]
36. Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands.
Font-Gonzalez A; Liu L; Voogd AC; Schmidt MK; Roukema JA; Coebergh JW; de Vries E; Soerjomataram I
Breast Cancer Res Treat; 2013 Jun; 139(3):811-9. PubMed ID: 23760860
[TBL] [Abstract][Full Text] [Related]
37. Socioeconomic inequalities in metastasis, recurrence, stage and grade of breast cancer: a hospital-based retrospective cohort study.
Taheri M; Tavakol M; Akbari ME; Anoshirvani AA; Aghabozorgi R; Almasi-Hashiani A; Abbasi M
J Prev Med Hyg; 2019 Sep; 60(3):E262-E269. PubMed ID: 31650064
[TBL] [Abstract][Full Text] [Related]
38. Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989.
Schrijvers CT; Coebergh JW; van der Heijden LH; Mackenbach JP
Cancer; 1995 Jun; 75(12):2946-53. PubMed ID: 7773946
[TBL] [Abstract][Full Text] [Related]
39. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.
van Laar C; van der Sangen MJ; Poortmans PM; Nieuwenhuijzen GA; Roukema JA; Roumen RM; Tjan-Heijnen VC; Voogd AC
Eur J Cancer; 2013 Oct; 49(15):3093-101. PubMed ID: 23800672
[TBL] [Abstract][Full Text] [Related]
40. Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.
Gierach GL; Curtis RE; Pfeiffer RM; Mullooly M; Ntowe EA; Hoover RN; Nyante SJ; Feigelson HS; Glass AG; Berrington de Gonzalez A
JAMA Oncol; 2017 Feb; 3(2):186-193. PubMed ID: 27711920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
